Menu
  • Join
  • Login
  • Contact
 

Search abstracts / presentations


The feasibility study of nanoparticles derived from Glycyrrhizae radix as a vaccine adjuvant for cancer immunotherapy

  • At: Seville (Spain) (2022)
  • Type: Poster
  • Poster code: DDD-029
  • By: SUZUKI, Yuno (Faculty of Pharma-Science, Teikyo University, Japan)
  • Co-author(s): Ms Yuno Suzuki, Graduate Student (Faculty of Pharma-Science, Teikyo University, Itabashi-ku, Japan)
    Dr Lisa Munakata (Faculty of Pharma-Science, Teikyo University, Itabashi-ku, Japan)
    Dr Daiki Omata (Faculty of Pharma-Science, Teikyo University, Itabashi-ku, Japan)
    Dr Akiko Inujima (Institute of Natural Medicine, University of Toyama, Toyama, Japan)
    Dr Keiichi Koizumi (Institute of Natural Medicine, University of Toyama, Toyama, Japan)
    Dr Ryo Suzuki (Faculty of Pharma-Science, Teikyo University, Itabashi-ku, Japan / Advanced Comprehensive Research Organization, Teikyo University, Itabashi-ku, Japan)
  • Abstract:

    Background and purpose
    Previously, we have reported that herbal medicines contain a lot of nanoparticles. In particular, we showed that Glycyrrhiza nanoparticles (Glycyrrhiza NP) derived from Glycyrrhizae Radix, one of the major herbal medicines induced the activation of macrophages and the production of inflammatory cytokines such as IL-6 and..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses